2014 CME Symposia - Breakfast Symposium A
Register for the CMHC today to sign up for these value-added CME/CE activities-at no additional cost!
Pre-registration for symposia will open at the end of August for CMHC registrants to make selections. There are no additional fees to attend. Symposia include meals or refreshments and seating is limited and on a first-come, first-serve basis.
CME Breakfast Symposium A
Thursday · 6:15 - 7:45am
The Triglycerides Conundrum: Practical Clinical Guidance for Reducing Residual CV Risk
Supported by an educational grant from Amarin Pharma, Inc.
Against the backdrop of escalating rates of obesity, metabolic syndrome and type 2 diabetes, hypertriglyceridemia is an increasingly relevant issue facing clinicians in their routine practice and cannot be ignored. Our faculty of nationally recognized experts will address current controversies in triglyceride management with the goal of providing the insight, strategies and practical guidance to effectively manage persistently elevated triglycerides in patients who remain at high CV risk. This symposium will evaluate the available triglyceride-lowering therapies, with a focus on omega-3 fatty acids, comparing and contrasting data on their safety, tolerability, differential effects on lipid-lowering and cardio-protective benefits.
- Evaluate current guideline recommendations concerning lipid management in patients with elevated triglycerides and/or mixed dyslipidemia to clinical practice.
- Describe the genetic and physiologic mechanisms by which elevated triglycerides impact cardiovascular risk.
- Assess the impact of diet, nutrient intake, and therapeutic lifestyle change in modifying elevated triglycerides and associated cardiovascular risk.
- Evaluate the safety, efficacy, tolerability, differential lipid-lowering effects and cardiovascular outcomes data on available therapeutic strategies for lowering triglycerides, including niacin, fibrates, and prescription omega-3 fatty acids.
- Enhance clinical decision-making when managing patients with elevated triglycerides and/or mixed dyslipidemia to optimize patient outcomes.
Preliminary Agenda & Faculty
|6:15 - 6:20am
||Chairperson: Harold E. Bays, MD
|6:20 - 6:40am
||The Relationship of Triglycerides to Cardiovascular Disease: To Treat or Not To Treat?
||Presenter: Christie M. Ballantyne, MD
|6:40 - 7:00am
||Lifestyle Matters: What's the Real Role of Nutritional and Lifestyle Interventions in Hypertriglyceridemia Management?
||Presenter: Harold E. Bays, MD
|7:00 - 7:20am
||Reducing Triglyceride Levels in At-Risk Patients: What Are Clinicians to Do?
||Presenter: Eliot A. Brinton, MD
|7:20 - 7:45am
||Expert Opinion and Best Practices for Managing Triglycerides and Residual CV Risk:
Interactive, Case-Based Scenarios, Panel Discussion and Debate along with Audience Q&A
|Moderator: Harold E. Bays, MD
Discussants: Eliot A. Brinton, MD; Christie M. Ballantyne, MD
View Complete Accreditation Details and Program Overview: CMHC Accreditation